ArticleArchives of microbiology2025
Whole genome sequencing to assess the safety and probiotic potential of Pediococcus pentosaceus L1 isolated from pickled radish.
Article in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The therapeutic potential ofFrontiers in microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
This research aimed for the safety and probiotic potential assessment of Pediococcus pentosaceus L1, isolated from pickled radish, through its whole genome sequencing analysis and in vitro evaluation. The genome size of Ped. pentosaceus L1 was 1,751,467 bp long with an average guanine-cytosine (GC) ratio of 37.41% and contained 1739 genes in the coding region. The functional annotation of the L1 strain demonstrated that it exhibited excellent probiotic potential and health-promoting properties, with numerous genes linked to the carbohydrate metabolism system, stress resistance, and environmental adaptation. The analysis of virulence factor and antimicrobial resistance indicated the absence of any virulence-related or antibiotic resistance genes in Ped. pentosaceus L1, adding value to its safety profile. In vitro experiments showed that Ped. pentosaceus L1 presented high cell surface hydrophobicity, strong antioxidant activity, no hemolytic activity, and did not synthesize biogenic amines including cadaverine, putrescine, or agmatine. Additionally, its auto- and co-aggregation survival rates indicated its probiotic potential. Ped. pentosaceus L1 also exhibited exceptional exopolysaccharide (EPS) production potential, achieving an enhanced EPS yield in a glucose-supplemented medium. Together, all these characteristics make Ped. pentosaceus L1 an optimistically safe choice for use as a potential probiotic.
Indexed as
Identifiers
41191059What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.